血液透析患者行腹腔镜胆囊切除术并发症发生率及临床安全性分析

Complication Incidence and Clinical Safety of Laparoscopic Cholecystectomy in Hemodialysis Patients

目的探讨腹腔镜胆囊切除术(LC)在血液透析(HD)患者中的应用价值。方法选取2020年2月至2021年2月我院收治的74例行LC患者作为研究对象,其中37例行LC的HD患者为研究组,同期37例行LC的肾功能正常患者为对照组。比较两组手术情况、康复情况及并发症。结果两组手术时间、术中出血量、通气恢复时间、住院时间相比,差异无统计学意义(P>0.05);观察组术后并发症总发生率为8.11%,与对照组的5.41%相比,差异无统计学意义(P>0.05)。结论HD合并胆囊疾病患者行LC术是安全可行的,术中出血量少,术后并发症发生率低,恢复快。

Objective This paper aims to investigate the application value of laparoscopic cholecystectomy(LC)in hemodialysis(HD)patients.Methods From February 2020 to February 2021,74 patients with LC in our hospital were selected as the research objects,37 HD patients with LC as the research group,and 37 patients with normal renal function as the control group.The operation,rehabilitation and complications were compared between the two groups.Results There was no significant difference in operation time,intraoperative blood loss,ventilation recovery time and hospital stay between the two groups(P>0.05);The total incidence of postoperative complications in the observation group was 8.11%,which was not significantly different from5.41%in the control group(P>0.05).Conclusion LC for HD patients with gallbladder disease is safe and feasible,with less intraoperative blood loss,low incidence of postoperative complications and quick recovery.